SEC Form 4 · accession 0001209191-18-020023
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pat Cotroneo
Officer — VP, Finance and CFO
Period of report
Mar 13, 2018
Accepted (ET)
Mar 15, 2018 · 8:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 13, 2018 | S | 5,932 | $54.61 | D | 168,334 | D | |
| Common StockF3 | Mar 14, 2015 | A | 28,000 | $0.00 | A | 196,334 | D | |
| Common Stock | Mar 15, 2018 | M | 14,000 | $19.39 | A | 210,334 | D | |
| Common Stock | Mar 15, 2018 | M | 22,094 | $29.66 | A | 232,428 | D | |
| Common StockF1,F4 | Mar 15, 2018 | S | 22,290 | $52.23 | D | 210,138 | D | |
| Common StockF1,F5 | Mar 15, 2018 | S | 13,804 | $53.08 | D | 196,334 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F6 | $53.75 | Mar 14, 2018 | A | 38,000 | A | — | Mar 14, 2028 | Common Stock | 38,000 | 38,000 | D |
| Stock Option (Right to Buy)F6 | $29.66 | Mar 15, 2018 | M | 22,094 | D | — | Mar 4, 2025 | Common Stock | 22,094 | 20,042 | D |
| Stock Option (Right to Buy)F6 | $19.39 | Mar 15, 2018 | M | 14,000 | D | — | Feb 22, 2026 | Common Stock | 14,000 | 46,000 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.
- F2The shares were sold at prices ranging from $54.15 to $55.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2019, and the remainder vests in equal amounts quarterly thereafter for the following three years.
- F4The shares were sold at prices ranging from $51.70 to $52.675. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The shares were sold at prices ranging from $52.70 to $53.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years.